Pharmacology Services

Our expertise in tailor-made models and a dynamic research group specializing in pharmacology services ensures that you will receive effective solutions for your drug discovery needs. With an extensive range of skills, established proficiency, and a commitment to success, we perform both conventional and distinctive pharmacology studies. These pharmacology services can be built for a translational pipeline to meet your research objectives and clinical needs.  

Our Range of Pharmacology Services:

PK/PD Services

Evaluate pharmacokinetics and pharmacodynamics at all phases of development with ELISAs for biologics, spectral flow cytometry for cell-based therapies, and mass spectrometry for small molecule.

Toxicology Studies

Advance your in vivo toxicology with general and specialized pharmacology services, including acute studies, chronic studies.

DMPK Service

Evaluate drug absorption, distribution, metabolism, and excretion with comprehensive DMPK services designed to support lead optimization and preclinical drug development.

Cell Based Assays

Leverage the capabilities of our state-of-the-art equipment, including systems that provide real-time quantitative live-cell imaging and analysis, as well as liquid handling robots and plate hoppers that support high throughput screening.

Lifespan Studies

Explore our lifespan and longevity studies to evaluate survival, healthspan, and age-related changes while investigating interventions targeting aging and age-related diseases.

Histology Services

Get your specimens turned into high-resolution digital slides, so they’re ready for standard staining, immunostaining, IHC, scanning, and scoring via automation or with the help of our board-certified pathologists.

Ophthalmology Models

Leverage our aged macular degeneration models and our custom models to develop novel ophthalmology treatments.

Oncology Models

Advance your oncology research with preclinical cancer models designed to evaluate antitumor efficacy, therapeutic response, and novel treatment strategies.

MASH Models

Explore our preclinical MASH models to evaluate liver inflammation, fibrosis, and metabolic dysfunction while advancing the development of novel liver disease therapeutics.

Cardiovascular Models

Leverage our cardiovascular disease models to investigate disease progression, evaluate therapeutic efficacy, and accelerate the development of novel cardiovascular treatments.

Metabolic Disease Models

Explore our preclinical metabolic disease models for obesity, diabetes, and related conditions to evaluate therapeutic efficacy and advance drug development.

Wound Healing Models

Advance wound healing research with preclinical models designed to evaluate wound closure, tissue regeneration, and the efficacy of novel therapeutic interventions.

Comprehensive Preclinical Pharmacology Services to Advance Drug Discovery and Development

Ichor Life Sciences provides comprehensive pharmacology services to support drug discovery and development across a broad range of therapeutic areas. Our capabilities include in vivo disease models, DMPK and PK/PD studies, oncology, ophthalmology, metabolic and cardiovascular disease models, wound healing, lifespan studies and much more. Through customized study designs, advanced analytical techniques, and specialized disease models, we help researchers evaluate therapeutic efficacy, characterize disease progression, and generate actionable data to advance promising drug candidates toward clinical development.

Reach IND with our pharmacology services.

Too many projects to think about? Stop dealing with multiple CROs when you can get everything done in one place.

Frequently Asked Questions

We’re different from other CROs, which tends to lead to a lot of questions. Here are the answers to some common ones related to our pharmacology services.